With the FDA as the exclusive arbiter of whether C
Post# of 148192
(Total Views: 687)
Posted On: 09/29/2022 1:52:30 PM
Quote:
With the FDA as the exclusive arbiter of whether CYDY can conduct future trials in Nash and/or cancer, it cannot be assumed that CYDY will ever conduct any trial during the sale period for the 350 million new shares.
I also can't assume you are posting that in good faith. If the FDA blocks Cytodyn when it is presented with good safety data then the FDA is exposing itself to a lawsuit.
(5)
(0)CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼